Results 151 to 160 of about 5,207 (190)
Some of the next articles are maybe not open access.
Biomarkers in Barrett Esophagus
Mayo Clinic Proceedings, 2001Barrett esophagus is a premalignant condition that may progress to adenocarcinoma. The risk of developing cancer has been estimated to be approximately 1 in 250 patient-years of observation; however, there appear to be subsets of patients at much higher risk. Risk stratification has previously been determined by histological identification of dysplasia.
Krishnadath, K. K. +2 more
openaire +2 more sources
Biomarkers in Barrett's esophagus
Gastrointestinal Endoscopy Clinics of North America, 2003This article provides a framework for clinicians who are attempting the difficult task of interpreting the Barrett's biomarker literature with the goal of improving care for their patients. Although many articles. including more that 60 proposed biomarkers, have been published on this subject, only a few describe phase 3 and 4 studies that are of ...
Brian J, Reid +2 more
openaire +2 more sources
BARRETT'S ESOPHAGUS AND ADENOCARCINOMA
Annual Review of Medicine, 1987Barrett's esophagus represents an epithelial metaplasia in which a columnar lining replaces normal squamous epithelium of the esophagus. It occurs in at least 10% of patients with chronic gastroesophageal reflux and is associated with an increased risk of adenocarcinoma of the esophagus.
B J, Reid, W M, Weinstein
openaire +2 more sources
Gastritis in Barrett's esophagus
World Journal of Surgery, 1995AbstractDuodenogastric reflux has been implicated in the pathogenesis of complicated Barrett's esophagus and gastric ulceration. A group of 123 Barrett's patients were followed for a mean of 41 months; 9 (7%) developed gastric ulceration (GU). Of the Barrett's patients treated by antireflux surgery, 14% developed GU.
R J, Mason, C G, Bremner
openaire +2 more sources
Journal of Gastroenterology and Hepatology
ABSTRACT Barrett's esophagus (BE) is a precancerous condition marked by the replacement of the normal stratified squamous epithelium in the distal esophagus with metaplastic columnar epithelium, typically resulting from chronic gastroesophageal reflux disease (GERD).
Antonio Al Hazzouri +6 more
openaire +2 more sources
ABSTRACT Barrett's esophagus (BE) is a precancerous condition marked by the replacement of the normal stratified squamous epithelium in the distal esophagus with metaplastic columnar epithelium, typically resulting from chronic gastroesophageal reflux disease (GERD).
Antonio Al Hazzouri +6 more
openaire +2 more sources
Postgraduate Medicine, 1989
PreviewBarrett's esophagus is a premalignant condition that should be suspected in any patient presenting with signs and symptoms of chronic reflux esophagitis. The condition itself is asymptomatic, so a high index of suspicion in patients with reflux symptoms is the key to diagnosis.
S E, Wilson, D, Arnstein
openaire +2 more sources
PreviewBarrett's esophagus is a premalignant condition that should be suspected in any patient presenting with signs and symptoms of chronic reflux esophagitis. The condition itself is asymptomatic, so a high index of suspicion in patients with reflux symptoms is the key to diagnosis.
S E, Wilson, D, Arnstein
openaire +2 more sources
Screening for Barrett’s Esophagus
Gastroenterology Clinics of North America, 2015There is substantial interest in identifying patients with premalignant conditions such as Barrett's esophagus (BE), to improve outcomes of subjects with esophageal adenocarcinoma. However, there is limited consensus on the rationale for screening, the appropriate target population, and optimal screening modality. Recent progress in the development and
Milli, Gupta, Prasad G, Iyer
openaire +2 more sources
Endotherapy for Barrett's Esophagus
American Journal of Gastroenterology, 2012Endotherapy is now the mainstay of therapy for Barrett's associated neoplasia. The approach should begin with confirmation of neoplasia by a gastrointestinal pathologist, patient counseling, and appropriate endoscopic work up. Detailed examination with high-resolution white light endoscopy is the most important tool for detection of neoplasia.
Vani J A, Konda, Irving, Waxman
openaire +2 more sources
Archives of Surgery, 1984
During a ten-year period, endoscopy demonstrated acid-peptic esophagitis in 439 patients. Forty of these patients (9.1%) had Barrett's esophagus. Adenocarcinoma was present in the columnar epithelium in 15 (37.5%) of the patients with Barrett's esophagus.
V A, Starnes +3 more
openaire +2 more sources
During a ten-year period, endoscopy demonstrated acid-peptic esophagitis in 439 patients. Forty of these patients (9.1%) had Barrett's esophagus. Adenocarcinoma was present in the columnar epithelium in 15 (37.5%) of the patients with Barrett's esophagus.
V A, Starnes +3 more
openaire +2 more sources